Inventor
LECLERC CLAUDE
FR26 patents
⚠️ This page may combine multiple inventors who share the name “LECLERC CLAUDE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PASTEUR INSTITUT
16 patentsUS5503829AApr 2, 1996
Recombinant mutants for inducing specific immune responses
PASTEUR INSTITUT58 citations95
US5871747AFeb 16, 1999
Antigen-carrying microparticles and their use in the indication of humoral or cellular responses
PASTEUR INSTITUT243 citations94
US6004763ADec 21, 1999
Antigen-carrying microparticles and their use in the induction of humoral or cellular responses
PASTEUR INSTITUT99 citations92
US5935580AAug 10, 1999
Recombinant mutants for inducing specific immune responses
PASTEUR INSTITUT33 citations92
US5679784AOct 21, 1997
Recombinant mutants for inducing specific immune responses
PASTEUR INSTITUT23 citations92
US6676946B2Jan 13, 2004
Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof
PASTEUR INSTITUT24 citations86
US8017132B2Sep 13, 2011
Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell
PASTEUR INSTITUT8 citations78
US7906123B1Mar 15, 2011
Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof
PASTEUR INSTITUT8 citations78
US9957301B2May 1, 2018
Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response
PASTEUR INSTITUT2 citations69
US6458362B1Oct 1, 2002
Recombinant VP2 parvoviral pseudo-particles encoding CTL or T-helper cell epitopes
PASTEUR INSTITUT13 citations64
US10899799B2Jan 26, 2021
Method for preparing multiple antigen glycopeptide carbohydrate conjugates
PASTEUR INSTITUT0 citations60
US9387243B2Jul 12, 2016
Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof
PASTEUR INSTITUT0 citations48
US7883712B2Feb 8, 2011
Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti
PASTEUR INSTITUT1 citations48
US10004794B2Jun 26, 2018
Vectors for molecule delivery to CD11b expressing cells
PASTEUR INSTITUT0 citations46
US9708596B2Jul 18, 2017
Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell
PASTEUR INSTITUT0 citations46
US7696326B2Apr 13, 2010
Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
PASTEUR INSTITUT0 citations37
LECLERC CLAUDE
3 patentsUS9095537B2Aug 4, 2015
Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response
LECLERC CLAUDE5 citations78
US9370564B2Jun 21, 2016
Vectors for molecule delivery to CD11b expressing cells
LECLERC CLAUDE2 citations54
US9155783B2Oct 13, 2015
Agents and methods based on the use of the EDA domain of fibronectin
LECLERC CLAUDE0 citations43
PREVILLE XAVIER-EDMOND-EDOUARD
2 patentsUS8637039B2Jan 28, 2014
Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof
PREVILLE XAVIER-EDMOND-EDOUARD5 citations79
US8628779B2Jan 14, 2014
Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof
PREVILLE XAVIER-EDMOND-EDOUARD8 citations79